VF
SNDX icon

Virtu Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Virtu Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,948
Closed -$258K – 2045
2023
Q4 		$258K Buy
+11,948
New +$184K 0.02% 680
2023
Q2 		– Sell
-39,932
Closed -$843K – 1993
2023
Q1 		$843K Buy
+39,932
New +$993K 0.09% 224
2021
Q1 		– Sell
-10,927
Closed -$243K – 1993
2020
Q4 		$243K Buy
+10,927
New +$227K 0.03% 755
2017
Q4 		– Sell
-17,931
Closed -$210K – 2961
2017
Q3 		$210K Buy
+17,931
New +$220K 0.01% 1798

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Virtu Financial's SNDX Position: Q1 2024 in Review

Virtu Financial sold out of Syndax Pharmaceuticals (SNDX) in Q1 2024, closing a stake of 11,948 shares — an estimated $258K sold.

Virtu Financial first reported a position in SNDX in Q3 2017 and held it in 4 quarters. The position peaked at $843K in Q1 2023. 189 funds tracked by Wall St. Rank hold SNDX as of Q1 2024.

  • Virtu Financial reported no remaining Syndax Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 11,948 Syndax Pharmaceuticals shares in Q1 2024, an estimated $258K.
  • Virtu Financial first reported a position in Syndax Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • Virtu Financial's Syndax Pharmaceuticals position peaked at $843K in Q1 2023.
  • 189 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.